There have been 17 recent insider transactions recorded for Ascentage Pharma Group International (AAPG), including 0 buys and 0 sells.
Notable insiders with recent activity include Lippman Marc E, Sidransky David, Bozilenko Marina. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — AAPG
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-18 |
Lippman Marc E |
Director |
Unknown |
63,895 |
- |
- |
- |
| 2026-03-18 |
Sidransky David |
Director |
Unknown |
66,550 |
- |
- |
- |
| 2026-03-18 |
Bozilenko Marina |
Director |
Unknown |
53,895 |
$8.14 |
$438.71K |
- |
| 2026-03-18 |
Yu Debra |
Director |
Unknown |
63,895 |
- |
- |
- |
| 2026-03-18 |
Ye Changqing |
Director |
Unknown |
66,550 |
- |
- |
- |
| 2026-03-18 |
Yang Dajun |
Chairman and CEO |
Unknown |
103,364 |
- |
- |
- |
| 2026-03-18 |
Lu Simon Dazhong |
Director |
Unknown |
63,895 |
- |
- |
- |
| 2026-03-18 |
Lippman Marc E |
Director |
Unknown |
27,965 |
- |
- |
- |
| 2026-03-18 |
Sidransky David |
Director |
Unknown |
28,850 |
- |
- |
- |
| 2026-03-18 |
Knapp Thomas J |
SVP/general Counsel |
Unknown |
38,938 |
- |
- |
- |
| 2026-03-18 |
Bozilenko Marina |
Director |
Unknown |
27,965 |
- |
- |
- |
| 2026-03-18 |
Yu Debra |
Director |
Unknown |
27,965 |
- |
- |
- |
| 2026-03-18 |
Ye Changqing |
Director |
Unknown |
28,850 |
- |
- |
- |
| 2026-03-18 |
Lu Simon Dazhong |
Director |
Unknown |
27,965 |
- |
- |
- |
| 2026-03-18 |
Wang Shaomeng |
Director |
Unknown |
27,965 |
- |
- |
- |
| 2026-03-18 |
Wei Ren |
Director |
Unknown |
18,850 |
$8.14 |
$153.44K |
- |
| 2026-03-18 |
Zhai Yifan |
Chief Medical Officer |
Unknown |
103,364 |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
